4-20704492-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001258345.3(PACRGL):c.11C>T(p.Ser4Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000209 in 1,613,556 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001258345.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PACRGL | NM_001258345.3 | c.11C>T | p.Ser4Leu | missense_variant | 2/9 | ENST00000503585.6 | NP_001245274.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PACRGL | ENST00000503585.6 | c.11C>T | p.Ser4Leu | missense_variant | 2/9 | 2 | NM_001258345.3 | ENSP00000423881 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 151822Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000756 AC: 19AN: 251208Hom.: 0 AF XY: 0.0000516 AC XY: 7AN XY: 135766
GnomAD4 exome AF: 0.000219 AC: 320AN: 1461734Hom.: 0 Cov.: 34 AF XY: 0.000212 AC XY: 154AN XY: 727148
GnomAD4 genome AF: 0.000112 AC: 17AN: 151822Hom.: 0 Cov.: 32 AF XY: 0.0000405 AC XY: 3AN XY: 74116
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 23, 2024 | The c.11C>T (p.S4L) alteration is located in exon 2 (coding exon 1) of the PACRGL gene. This alteration results from a C to T substitution at nucleotide position 11, causing the serine (S) at amino acid position 4 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at